KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Elanco Animal Health (ELAN) Shares Outstanding (Weighted Average) (2017 - 2025)

Historic Shares Outstanding (Weighted Average) for Elanco Animal Health (ELAN) over the last 9 years, with Q3 2025 value amounting to $496.8 million.

  • Elanco Animal Health's Shares Outstanding (Weighted Average) rose 50.58% to $496.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $496.8 million, marking a year-over-year increase of 50.58%. This contributed to the annual value of $494.0 million for FY2024, which is 34.53% up from last year.
  • According to the latest figures from Q3 2025, Elanco Animal Health's Shares Outstanding (Weighted Average) is $496.8 million, which was up 50.58% from $496.6 million recorded in Q2 2025.
  • Elanco Animal Health's 5-year Shares Outstanding (Weighted Average) high stood at $496.8 million for Q3 2025, and its period low was $486.7 million during Q1 2021.
  • Over the past 5 years, Elanco Animal Health's median Shares Outstanding (Weighted Average) value was $492.3 million (recorded in 2023), while the average stood at $491.3 million.
  • In the last 5 years, Elanco Animal Health's Shares Outstanding (Weighted Average) soared by 2050.01% in 2021 and then grew by 22.57% in 2022.
  • Elanco Animal Health's Shares Outstanding (Weighted Average) (Quarter) stood at $487.2 million in 2021, then rose by 0.23% to $488.3 million in 2022, then increased by 0.82% to $492.3 million in 2023, then increased by 0.35% to $494.0 million in 2024, then grew by 0.57% to $496.8 million in 2025.
  • Its last three reported values are $496.8 million in Q3 2025, $496.6 million for Q2 2025, and $495.1 million during Q1 2025.